Technical Analysis for OPNT - Opiant Pharmaceuticals, Inc.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Strong | Up | Up | Down |
| See historical OPNT trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | -1.03% | |
| Inside Day | Range Contraction | -1.03% | |
| Wide Bands | Range Expansion | -1.03% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | -4.13% | |
| Stochastic Reached Overbought | Strength | -4.13% | |
| Outside Day | Range Expansion | -4.13% | |
| Wide Bands | Range Expansion | -4.13% | |
| Overbought Stochastic | Strength | -4.13% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/08/2019
- Sector: Healthcare
- Industry: Biotechnology
Opiant Pharmaceuticals, Inc., formerly Lightlake Therapeutics, Inc., is a specialty pharmaceutical company. The Company develops pharmacological treatments for substance use, addictive and eating disorders. The Company has developed NARCAN (naloxone hydrochloride) Nasal Spray, a treatment to reverse opioid overdoses, which was conceived, licensed, developed and approved by the United States Food and Drug Administration (FDA). The Company's pipeline of product candidates includes a treatment for Binge Eating Disorder (BED), a treatment for Bulimia Nervosa (BN), a treatment for Cocaine Use Disorder (CocUD) and a heroin vaccine. The Company also is focused on other treatment opportunities.
Medicine Chemistry Pharmaceutical Organic Chemistry Company's Pipeline Addiction Bulimia Nervosa Heroin Naloxone United States Food And Drug Administration
Medicine Chemistry Pharmaceutical Organic Chemistry Company's Pipeline Addiction Bulimia Nervosa Heroin Naloxone United States Food And Drug Administration
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more OPNT news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 29.55 |
| 52 Week Low | 9.98 |
| Average Volume | 19,849 |
| 200-Day Moving Average | 13.718 |
| 50-Day Moving Average | 13.3816 |
| 20-Day Moving Average | 13.6322 |
| 10-Day Moving Average | 14.9555 |
| Average True Range | 0.7638 |
| ADX | 25.9 |
| +DI | 19.051 |
| -DI | 17.9195 |
| Chandelier Exit (Long, 3 ATRs ) | 13.6086 |
| Chandelier Exit (Short, 3 ATRs ) | 13.2914 |
| Upper Bollinger Band | 16.5405 |
| Lower Bollinger Band | 10.7239 |
| Percent B (%b) | 0.63 |
| BandWidth | 42.668095 |
| MACD Line | 0.5458 |
| MACD Signal Line | 0.4812 |
| MACD Histogram | 0.0646 |
| Fundamentals | Value |
|---|---|
| Market Cap | 29.29 Million |
| Num Shares | 2.04 Million |
| EPS | 2.94 |
| Price-to-Earnings (P/E) Ratio | 4.89 |
| Price-to-Sales | 4.44 |
| Price-to-Book | 18.77 |
| PEG Ratio | 0.00 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 15.18 | ||||
| Resistance 3 (R3) | 15.19 | 14.93 | 15.05 | ||
| Resistance 2 (R2) | 14.93 | 14.73 | 14.92 | 15.00 | |
| Resistance 1 (R1) | 14.65 | 14.60 | 14.53 | 14.65 | 14.96 |
| Pivot Point | 14.40 | 14.40 | 14.33 | 14.39 | 14.40 |
| Support 1 (S1) | 14.12 | 14.19 | 13.99 | 14.11 | 13.80 |
| Support 2 (S2) | 13.86 | 14.07 | 13.86 | 13.76 | |
| Support 3 (S3) | 13.59 | 13.86 | 13.71 | ||
| Support 4 (S4) | 13.58 |
